A Study of BRCA1 Gene Exon 2 Mutation in Bangladeshi Female Breast Cancer Patients
Abstract
Keywords
Full Text:
PDFReferences
Globocan 2018. Breast- global Cancer Observatory-iarc 2018.
NICRH (2015). Hospital-based Cancer Registry Report 2014. Department of Cancer Epidemiology, National Institute of Cancer Research and Hospital (NICRH), Mohakhali, Dhaka, pp 2-21.
Zayas-Villanueva OA, Luis Daniel C-A, Lugo-Trampe JJ, Hernández-Barajas D, González-Guerrero JF, Noriega-Iriondo MF et al. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study. BMC Cancer 2019; 19(722): p- 2.
Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK. Hereditary breast & ovarian cancer: New genes, new treatments, new concepts. Dtsch Arztebl International 2011; 108(19): 323–330.
Bhatta B, Thapa R, Shahi S, Bhatta Y, Pandeya DR, Poudel BR. A pilot study on screening for BRCA1 mutations (185DelAG, 1294Del40) in Nepalese breast cancer patients. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 1829-1832.
Karami F, Mehdipour PA. Comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Research International 2013; 2013(928562): 1-21.
Hartwig M, Janiszewska H, Bąk A, Pilarska M, Heise M, Junkiert-Czarnecka A et al. Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country. Contemporary Oncology (Poznan) 2013; 17(1): 34-37.
Chakraborty A, Banerjee D, Basak J, Mukhopadhyay A. Absence of 185delAG and 6174delT mutations among breast cancer patients of Eastern India. Asian Pacific Journal of Cancer Prevention 2014; 16(17): 7929-7933.
Mary A, Rajan A, Selvi R, Paul SFD. A pilot study on screening for 185delAG mutation in breast cancer patients in a tertiary care center from South India. Sri Ramachandra Journal of Medicine 2010; 3(2): 9-11.
Kim H, Choi DH. Distribution of BRCA1 and BRCA2 mutations in Asian patients with breast cancer. J Breast Cancer 2013; 16(4): 357-365.
Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M. The founder mutations 185delAG & 5382insC in BRCA1 & 6174delT in BRCA2 appear in 60% of ovarian cancer & 30% of early-onset breast cancer patients among Ashkenazi women. American Jounal of Human Geneics 1997; 60: 505-514.
Shiovitz, Korde. Genetics of breast cancer: a topic in evolution. Annals of Oncology 2015; 26 (7):1291-1299.
Sharma S, Rajaram S, Sharma T, Goel N, Agarwal S, Banerjee BD. Role of BRCA1 and BRCA2 gene mutations in epithelial ovarian cancer in Indian population: A pilot study. International Journal of Biochemistry and Molecular Biology 2014; 5(1): 1-10.
Jaure, O, Alonso, EN, Braico, DA, Nieto, A, Orozco, M, Morelli, C, Ferro, AM, Elena B, Vincent, E, Martínez, D, Martínez, I, Maegli, MI, Frizza, A, Kowalyzyn, R, Salvadori, M, Ginestet, P, Donna, MLG & Balogh, GA 2015, 'BRCA1 polymorphism in breast cancer patients from Argentina', Oncology Letters, vol. 9, pp. 845-850.
DOI: https://doi.org/10.7575/aiac.abcmed.v.10n.4p.1
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
2013-2023 (CC-BY) Australian International Academic Centre PTY.LTD.
Advances in Bioscience and Clinical Medicine